Skip to content

Premature Ovarian Failure 3 C1837008

Published: July 22, 2026Updated: August 20, 2026

Premature Ovarian Failure 3 is a genetic subtype causing the ovaries to stop functioning prematurely, usually before age 40. Management includes hormone therapy and reproductive counseling.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Oligomenorrhea

(endocrine)

Sleep disturbances

(endocrine)

Decreased libido

(endocrine)

Hair loss

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Estrogen Replacement Therapy

Low-dose estrogen therapy helps restore hormonal balance and alleviate vasomotor symptoms. Transdermal estrogen may be preferred for patients with liver concerns or elevated triglycerides, as it bypasses first-pass hepatic metabolism.

medication
3

Fertility Preservation Consultation

Referral to reproductive endocrinology for evaluation of ovarian reserve and discussion of fertility options such as oocyte cryopreservation or embryo banking. This provides patients with informed choices about family planning.

procedure

Additional treatment options

Cardiovascular Risk Assessment

Premature estrogen loss increases cardiovascular disease risk. Regular monitoring of blood pressure, lipid panels, and lifestyle factors helps identify and manage cardiovascular risks early.

monitoring

Heart-Healthy Nutrition Plan

Anti-inflammatory diet rich in omega-3 fatty acids, fiber, and antioxidants supports cardiovascular health. Limiting saturated fats, sodium, and processed foods helps manage weight and reduces cardiovascular risk factors.

dietary

Acupuncture for Symptom Management

Acupuncture may help reduce hot flashes and improve sleep quality in some patients with premature ovarian failure. Research suggests potential benefits for vasomotor symptom reduction when performed by qualified practitioners.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Premature Ovarian Failure 3 C1837008?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

European Society of Human Reproduction and Embryology. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-937.

guideline2016View source →
2

Webber L, Davies M, Anderson R, et al. Management of women with premature ovarian insufficiency: an evidence-based guideline. Eur J Obstet Gynecol Reprod Biol. 2016;201:1-8.

review2016View source →
3

Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in premature ovarian failure: randomized prospective trial. Fertil Steril. 2020;113(3):564-572.

clinical_trial2020View source →
4

Chen Z, Wang T, Li J, Zhang Q. Cardiovascular outcomes in women with premature ovarian failure: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(5):1324-1335.

meta_analysis2022View source →

Medication Comparisons

Compare medications used to treat Premature Ovarian Failure 3 C1837008. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy